The Board Meeting to be held on 07/02/2026 has been revised to 04/02/2026 The Board Meeting to be held on 07/02/2026 has been revised to 04/02/2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has rescheduled its board meeting from 7 February 2026 to 4 February 2026. The meeting will be held at the registered office in Ahmedabad to consider and approve the unaudited financial results for the quarter ended 31 December 2025, along with the auditor's limited review report. Any other business with the chairman's permission may also be taken up. This is a routine procedural intimation under SEBI Listing Regulations with no financial figures disclosed yet.
No direct impact on shareholders — this is just an administrative date change. The actual Q3 results, when announced on or after 4 February 2026, will be the key catalyst for stock movement.